SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-08-027259
Filing Date
2008-05-09
Accepted
2008-05-09 13:58:19
Documents
1
Period of Report
2008-05-07

Document Format Files

Seq Description Document Type Size
1 v113455_ex.html 4  
1 v113455_ex.xml 4 3735
  Complete submission text file 0001144204-08-027259.txt   5680
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 972-54-7909058
KIDRON NADAV (Reporting) CIK: 0001351779 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50298 | Film No.: 08817543